Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman

RTTNews | 502 days ago
Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman

(RTTNews) - Biopharmaceutical company Protalix BioTherapeutics, Inc. (PLX) announced Tuesday that the Company's Board of Directors has appointed Eliot Richard Forster to serve on the Board of Directors as its Chairman, effective as of September 14, 2023.

In addition to Forster's appointment as Chairman and an independent director, he was also appointed to serve on the Company's Nominating Committee. Zeev Bronfeld, the current Chairman of the Company's Board of Directors, will retire on the same day.

Forster currently serves as the Non-Executive Chairman of Avacta Group PLC (AVCT), as a Non-Executive Director of Immatics NV (IMTX) and as the Non-Executive Chairman of Ochre Bio, Inc., a private biotechnology company.

Forster served as the Chief Executive Officer of F-Star Therapeutics Ltd., a clinical-stage bispecific antibodies company, until its March 2023 sale to inovoX Ltd. Prior to that, he served as CEO of Immunocure Ltd., CEO of Creabilis SA and President and CEO of Solace Pharmaceuticals Inc., each of which was a privately-held life science company.

Earlier in his career, he held positions at Pfizer Global Research & Development and Glaxo/GlaxoWellcome.

read more
Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Protalix BioTherapeutics, Inc. (PLX) and Chiesi Global Rare Diseases, a business unit of the Chiesi Group, announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending marketing authorization for PRX-102 (pegunigalsidase alfa), the first and only pegylated enzyme for the treatment of adult patients with Fabry disease.
RTTNews | 702 days ago
Asian Markets Trade Mixed

Asian Markets Trade Mixed

Asian stock markets are trading mixed on Monday, following the broadly positive cues from Wall Street on Friday, paring early gains after the release of disappointing Chinese industrial profits, manufacturing and non-manufacturing data. Traders also remain cautious ahead of the monetary policy decisions from the US Fed and the European Central Bank later in the week.
RTTNews | 6h 21min ago
Japanese Market Notably Lower

Japanese Market Notably Lower

The Japanese stock market is notably lower on Monday after opening in the green, extending the losses in the previous session, with the Nikkei 225 is falling well below the 39,800 level, following the broadly negative cues from Wall Street on Friday, with weakness index heavyweights and technology stocks partially offset by gains in financial stocks.
RTTNews | 7h 14min ago
China Manufacturing PMI Ebbs In January - NBS

China Manufacturing PMI Ebbs In January - NBS

The manufacturing sector in China fell into contraction in January, the latest survey from the National Bureau of Statistics said on Monday with a manufacturing PMI score of 49.1.
RTTNews | 7h 29min ago
Thai Stock Market May Head South Again On Monday

Thai Stock Market May Head South Again On Monday

The Thai stock market bounced higher again on Friday, one day after ending the two-day winning streak in which it had improved more than 20 points or 1.6 percent. The Stock Exchange of Thailand now sits just beneath the 1,355-point plateau although it figures to see renewed consolidation on Monday.
RTTNews | 8h 10min ago
Soft Start Anticipated For Hong Kong Stock Market

Soft Start Anticipated For Hong Kong Stock Market

The Hong Kong stock market on Friday wrote a finish to the two-day slide in which it had slumped more than 400 points or 2 percent. The Hang Seng now sits just above the 20,060-point plateau although it may hand back some of those gains on Monday.
RTTNews | 8h 40min ago